A detailed history of Sherbrooke Park Advisers LLC transactions in Pfizer Inc stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 26,269 shares of PFE stock, worth $772,833. This represents 0.13% of its overall portfolio holdings.

Number of Shares
26,269
Holding current value
$772,833
% of portfolio
0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $663,554 - $777,562
26,269 New
26,269 $735 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $2,085 - $2,438
-65 Reduced 0.41%
15,935 $529 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $205,883 - $238,203
-5,700 Reduced 26.27%
16,000 $587 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $854,763 - $1.11 Million
21,700 New
21,700 $885 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $165B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.